These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4213473)

  • 21. Coagulation in the human fetus. Comparison with term newborn infants.
    Holmberg L; Henriksson P; Ekelund H; Astedt B
    J Pediatr; 1974 Dec; 85(6):860-4. PubMed ID: 4425094
    [No Abstract]   [Full Text] [Related]  

  • 22. Purification and some characteristics of the human coagulation factor VII.
    Flengsrud R
    Eur J Biochem; 1979 Aug; 98(2):455-64. PubMed ID: 114392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prothrombin: a unit or complex?].
    Voss D
    Klin Wochenschr; 1967 May; 45(9):449-52. PubMed ID: 4967529
    [No Abstract]   [Full Text] [Related]  

  • 24. Purification and sensitive immunoelectrophoretical detection and quantitation of human 1 -foetoprotein.
    Norgaard-Pedersen B
    Clin Chim Acta; 1972 Apr; 38(1):163-70. PubMed ID: 4624225
    [No Abstract]   [Full Text] [Related]  

  • 25. Removal of hepatitis B surface antigen (HBsAg) from plasma fractions.
    Johnson AJ; Semar M; Newman J; Harris RB; Brandt D; Middleton S; Smith J
    J Lab Clin Med; 1976 Jul; 88(1):91-101. PubMed ID: 932537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological studies on the blood coagulation Factor X and its warfarin-induced precursor.
    Gaudernack G; Berre AG; Osterud B; Prydz H
    Thromb Diath Haemorrh; 1974 Mar; 31(1):40-51. PubMed ID: 4209391
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on alpha2-macroglobulins.
    Richter P; Kocsis GY; Varró R; Thury I
    Ann Immunol Hung; 1973; 17():33-7. PubMed ID: 4142676
    [No Abstract]   [Full Text] [Related]  

  • 28. Human secretory component. I. Purification of free secretory component from colostrum.
    Brandtzaeg P
    Scand J Immunol; 1974; 3(5):579-88. PubMed ID: 4214117
    [No Abstract]   [Full Text] [Related]  

  • 29. Contributions to the optimal use of human blood. VI. Modification of the method to prepare prothrombin complex on a large scale.
    Heystek J; Maier-van der Zande GM; Brummelhuis HG; Krijnen HW
    Vox Sang; 1975; 29(3):177-83. PubMed ID: 806173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A procedure for isolation of human protein C and protein S as by-products of the purification of factors VII, IX, X and prothrombin.
    Bajaj SP; Rapaport SI; Maki SL; Brown SF
    Prep Biochem; 1983; 13(3):191-214. PubMed ID: 6226944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Purification of blood coagulation factors II, VII, IX and X from bovine citrated plasma.
    Reekers P; Hemker HC
    Haemostasis; 1972; 1(1):2-22. PubMed ID: 4668761
    [No Abstract]   [Full Text] [Related]  

  • 32. A conserved epitope on several human vitamin K-dependent proteins. Location of the antigenic site and influence of metal ions on antibody binding.
    Church WR; Messier T; Howard PR; Amiral J; Meyer D; Mann KG
    J Biol Chem; 1988 May; 263(13):6259-67. PubMed ID: 2452160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of bovine prothrombin, factor IX (Christmas factor), and factor X (Stuart factor).
    Fujikawa K; Coan MH; Enfield DL; Titani K; Ericsson LH; Davie EW
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):427-30. PubMed ID: 4205592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A human plasma fraction (PPSB) enriched with the coagulation factors II, VII, IX and X].
    Richter K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1970; 93(3):340-3. PubMed ID: 4195279
    [No Abstract]   [Full Text] [Related]  

  • 35. Specific coagulation factor adsorption to insoluble heparin.
    Gentry PW; Alexander B
    Biochem Biophys Res Commun; 1973 Jan; 50(2):500-9. PubMed ID: 4689062
    [No Abstract]   [Full Text] [Related]  

  • 36. C1q protein of human complement.
    Calcott MA; Müller-Eberhard HJ
    Biochemistry; 1972 Aug; 11(18):3443-50. PubMed ID: 4626765
    [No Abstract]   [Full Text] [Related]  

  • 37. The use of an immunoadsorbent in the isolation of Australia antigen.
    Houwen B; Marrink J; Vos J; Molenaar I; Nieweg HO
    Vox Sang; 1973; 24():Suppl:114-22. PubMed ID: 4198167
    [No Abstract]   [Full Text] [Related]  

  • 38. Development of large-scale fractionation methods. II. Isolation of a factor IX concentrate (prothrombin complex) for clinical use.
    Wickerhauser M; Sgouris JT
    Vox Sang; 1972; 22(2):137-60. PubMed ID: 5013242
    [No Abstract]   [Full Text] [Related]  

  • 39. Characterization and experimental use of a monospecific antiserum to factor IX.
    Pechet L; Tiarks CY; Chang CH; Sudhindra RR; Lipworth L
    Thromb Haemost; 1979 Feb; 40(3):455-64. PubMed ID: 106483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the prothrombin complex, I. Behavior of prothrombin, factor VII, IX and X on barium sulfate].
    Voss D
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1163-71. PubMed ID: 4968304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.